About
Wayfinder Biosciences develops orally available small molecule drugs that selectively bind to target RNA molecules to prevent the production of disease-causing proteins, focusing on indications such as oncology and neurodegeneration.
Explore Wayfinder Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.